Global Targeted Therapeutics Market Size By Product Type(Monoclonal Antibodies, Small Molecules), By Application(Breast Cancer, Leukemia, Lymphoma), By Distribution Channel(Hospital Pharmacies, Online Pharmacies), By Geographic Scope And Forecast
Global Targeted Therapeutics Market Size By Product Type(Monoclonal Antibodies, Small Molecules), By Application(Breast Cancer, Leukemia, Lymphoma), By Distribution Channel(Hospital Pharmacies, Online Pharmacies), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Targeted Therapeutics Market Size By Product Type(Monoclonal Antibodies, Small Molecules), By Application(Breast Cancer, Leukemia, Lymphoma), By Distribution Channel(Hospital Pharmacies, Online Pharmacies), By Geographic Scope And Forecast
Targeted Therapeutics Market Size and Forecast
Targeted Therapeutics Market size was valued at USD 55 billion in 2021, it is expected to reach USD 125 billion by the end of 2030, growing at a CAGR of 2.6% from 2023 to 2030.
The growing burden of severe diseases like leukemia, cancer, muscular degeneration, and lymphoma is boosting growth in the targeted therapeutics market globally. The Global Targeted Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Targeted Therapeutics Market Definition
Targeted therapeutics refer to a form of medical treatment that involves the use of drugs or other therapies designed to target specific molecules or cells in the body that are responsible for causing or contributing to a disease or condition. This approach is in contrast to traditional non-targeted therapies that are designed to affect all cells or molecules in the body, including healthy ones. Targeted therapeutics can be used to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases.
The targeted therapeutics market has been rapidly growing in recent years due to the increasing demand for more personalized and effective treatments for various diseases. The market includes a wide range of products, including monoclonal antibodies, small molecule inhibitors, and other biologic therapies. Advancements in technology and the growing understanding of disease mechanisms have made it possible to develop more precise and targeted therapies, which has further contributed to the growth of the market. The market is expected to continue to grow in the coming years as new therapies are developed and as the demand for personalized medicine continues to increase.
What's inside a industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Targeted Therapeutics Market Overview
The COVID-19 pandemic has had a significant impact on the targeted therapeutics market. On one hand, the pandemic has increased the demand for targeted therapies as the world has struggled to find effective treatments for the virus. Many researchers and pharmaceutical companies have focused their efforts on developing targeted therapeutics to combat COVID-19, resulting in an increase in research and development activities in this area.
The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is increasing globally, which is driving the demand for more targeted and effective therapies. The development of new technologies such as genomics, proteomics, and personalized medicine is driving the growth of the targeted therapeutics market. These technologies enable the identification of specific disease targets and the development of more targeted therapies. Collaboration between pharmaceutical companies and research institutions is driving the growth of the targeted therapeutics market. These collaborations facilitate the development of more effective therapies by combining expertise and resources.
While there are several drivers of growth in the targeted therapeutics market, there are also several factors that may restrain its growth. The development of targeted therapeutics is a complex and expensive process, requiring significant investment in research and development. The high costs associated with developing these therapies may limit the number of companies that can participate in the market, and ultimately limit the availability of new targeted therapies. The regulatory approval process for targeted therapeutics can be lengthy and complex. Strict regulations and guidelines are in place to ensure the safety and efficacy of these therapies, which can increase the time and cost required for regulatory approval.
There are several opportunities for growth in the targeted therapeutics market. Combination therapies that target multiple disease pathways or targets simultaneously may be more effective than single-targeted therapies. The development of combination therapies is an opportunity for growth in the targeted therapeutics market. The use of digital technologies, such as artificial intelligence and machine learning, in drug discovery and development, is an opportunity for growth in the targeted therapeutics market. These technologies can accelerate the drug development process and improve the efficacy of targeted therapies.
Targeted Therapeutics MarketSegmentation Analysis
The Targeted Therapeutics Market is segmented by product type, application, distribution channel, and region.
Targeted Therapeutics Market, By Product Type
• Monoclonal Antibodies• Small Molecules
The monoclonal antibodies segment of Targeted Therapeutics Market holds the largest revenue share as per the report of 2020. It is one of the most operative drugs that is used to treat cancer. Besides this, the other segments are also developing steadily in the global market.
The breast cancer segment is anticipated to grow faster as compared to the other segments. It is one of the most prevalent cancer types. The growing number of breast cancer cases has increased the growth in the segment.
Targeted Therapeutics Market, By Distribution Channel
The hospital pharmacies are the largest segment in this market and it is expected to sustain its dominance in the global market. Besides this, the increasing expenditure for the private and public organization has also developed the infrastructure for the hospital pharmacies in the Targeted Therapeutics Market global market.
Targeted Therapeutics Market, By Geography
• North America• Europe• Asia-Pacific• Latin America• Middle East & Africa
The North America segment holds the largest revenue in the global market, and it is projected to sustain its dominance in the forecast years. Increasing growth of biologic sector in North-America is boosting the growth of Targeted Therapeutics Market in this region.
Key Players
The major players in the Targeted Therapeutics Market are Pfizer Inc., Amgen Inc., AstraZeneca Plc., Agenus Inc., Genetech Inc., Nektar Therapeutics Inc., Sanofi, Aurinia Pharmaceuticals Inc., Serena Therapeutics Inc., Arcus Biosciences Inc., F. Hoffmann-La Roche & Co., Celdara Medical LLC, and Gileas Sciences Inc.
These companies are focusing on developing more advanced solutions with the help of technical integrations and strategic partnerships with other companies.
Key Developments
In December 2022, Genetech Inc., got the approval from United States FDA to perform Tecentriq for pediatric patients and adults that are suffering from unresectable alveolar soft part sarcoma (ASPS)
In September 2020, Sanofi acquired Principia Biopharma in order to enhance the field of autoimmune diseases and allergic diseases.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2019-2030
BASE YEAR
2022
FORECAST PERIOD
2023-2030
HISTORICAL PERIOD
2019-2021
UNIT
VALUE(USD(BILLION))
KEY COMPANIES PROFILED
Pfizer Inc., Amgen Inc., AstraZeneca Plc., Agenus Inc., Genetech Inc., Nektar Therapeutics Inc., Sanofi, Aurinia Pharmaceuticals Inc., Serena Therapeutics Inc., Arcus Biosciences Inc., F. Hoffmann-La Roche & Co., Celdara Medical LLC, and Gileas Sciences Inc.
SEGMENTS COVERED
By Product Type, By Application, By Distribution Channel, By Geography.
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements are met.
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Targeted Therapeutics Market Size By Product Type(Monoclonal Antibodies, Small Molecules), By Application(Breast Cancer, Leukemia, Lymphoma), By Distribution Channel(Hospital Pharmacies, Online Pharmacies), By Geographic Scope And Forecast
